| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 804,285 | $80,412,421.00 | 4.38% |
| AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 22,525,000 | $21,523,606.00 | 1.17% |
| Goldman Sachs Group, Inc. 4.939% 10/21/2036 (USD-SOFR + 1.33% on 10/21/2035) | Fixed Income | 20,567,000 | $18,666,116.00 | 1.02% |
| U.S. Treasury 5.00% 9/30/2031 | Fixed Income | 17,759,100 | $17,702,908.00 | 0.96% |
| U.S. Treasury 4.375% 9/15/2029 | Fixed Income | 15,877,400 | $15,615,051.00 | 0.85% |
| U.S. Treasury 5.125% 8/15/2046 | Fixed Income | 16,779,000 | $15,696,230.00 | 0.85% |
| Chubb INA Holdings, LLC 5.00% 3/15/2034 | Fixed Income | 15,727,000 | $14,854,828.00 | 0.81% |
| Morgan Stanley 4.892% 10/22/2036 (USD-SOFR + 1.314% on 10/22/2035) | Fixed Income | 16,290,000 | $14,764,800.00 | 0.8% |
| U.S. Treasury 5.00% 5/15/2056 | Fixed Income | 15,375,100 | $13,994,345.00 | 0.76% |
| Bank of America Corp. 2.299% 7/21/2032 (USD-SOFR + 1.22% on 7/21/2031) | Fixed Income | 15,173,000 | $12,928,397.00 | 0.7% |
| JPMorgan Chase & Co. 4.81% 10/22/2036 (USD-SOFR + 1.19% on 10/22/2035) | Fixed Income | 14,155,000 | $12,885,098.00 | 0.7% |
| Abbott Laboratories 4.65% 3/15/2036 | Fixed Income | 13,934,000 | $12,703,029.00 | 0.69% |
| Morgan Stanley 4.708% 3/12/2032 (USD-SOFR + 1.195% on 3/12/2031) | Fixed Income | 12,988,000 | $12,359,796.00 | 0.67% |
| U.S. Treasury 4.625% 8/15/2036 | Fixed Income | 12,685,400 | $12,053,112.00 | 0.66% |
| Boeing Co. (The) 3.25% 2/1/2028 | Fixed Income | 11,002,000 | $10,724,750.00 | 0.58% |